Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy-Reference-Cited by-同舟云学术

Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy

Published:2021-10-19 Issue:6 Volume:14 Page:1725-1732
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Sato Ken^ORCID,Kanayama Yuki,Yamazaki Yuichi,Tojima Hiroki,Suga Takayoshi,Uehara Daisuke,Kakizaki Satoru,Yanagisawa Kunio,Uraoka Toshio,Ohnishi Hiroshi,Okamoto Hiroaki

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12328-021-01524-1.pdf

Reference28 articles.

1. Spearman CW, Dusheiko GM, Hellard M, et al. Hepatitis C. Lancet. 2019;394:1451–66.

2. Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:161–76.

3. Hayashi K, Fukuda Y, Nakano I, et al. Prevalence and characterization of hepatitis C virus genotype 4 in Japanese hepatitis C carriers. Hepatol Res. 2003;25:409–14.

4. Totsuka M, Honda M, Kanda T, et al. Japanese man with HCV genotype 4 infection and cirrhosis who was successfully treated by the combination of glecaprevir and pibrentasvir. Intern Med. 2021;60:2061–6.

5. Nagao A, Hanabusa H. Brief report: the impact of ledipasvir/sofosbuvir on HIV-positive and HIV-negative Japanese hemophilia patients with 1, 4, and mixed-genotype HCV. J Acquir Immune Defic Syndr. 2017;74:418–22.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glecaprevir/pibrentasvir/peginterferon-alfa-2a/ribavirin/peginterferon-alfa-2b/ribavirin;Reactions Weekly;2023-01-07